Manufacturing Facilities

Taj Pharmaceuticals stands as a global leader in the pharmaceutical industry, committed to delivering high-quality medications that adhere to the most stringent international standards. With advanced manufacturing plants located strategically across India, Taj Pharma has carved a niche for itself in various therapeutic segments, including oncology, nutraceuticals, and antibiotics. Each facility embodies cutting-edge technology, innovative processes, and unparalleled production capabilities, ensuring a steady supply of essential medicines worldwide.


Sarigam GIDC Manufacturing Plant: A Pillar of Excellence

The Sarigam GIDC Manufacturing Plant is a cornerstone of Taj Pharmaceuticals’ operations, designed to cater to diverse pharmaceutical needs. The facility is equipped with state-of-the-art technology and adheres to stringent global quality standards, including EU GMP and PIC/S compliance.

Key Capacities and Product Offerings:

  • Tablets: With a production capacity of 120 million tablets per month, the plant supports various therapeutic segments, ensuring widespread availability.
  • Capsules: This facility produces 40 million capsules per month, meeting the demand for essential dosage forms.
  • Dry Blended Powders/Granules: A capacity of 20 million units per month makes the plant a leader in this category.
  • Effervescent Tablets: Producing 20 million units monthly, these tablets are tailored for ease of use and patient compliance.
  • Oral Jelly: With 60 million units produced per month, this dosage form is a favorite for patients requiring easy administration.
  • Creams/Ointments: Manufacturing 40 million units per month, the plant supports a wide array of topical treatments.
  • Oral Sachets: Capable of producing 3 million sachets per month, these offer convenient medication delivery.

Kalgam Village Injections Plant: Precision in Parenteral Solutions

The Kalgam Village plant is specialized in the production of liquid and dry powder injections, catering to critical pharmaceutical needs. This facility ensures stringent quality control, providing parenteral medications that meet global healthcare standards.

Shift-wise Production Capacities:

  • Liquid Ampoule Injections: 2.5 lakh units per shift.
  • Liquid Vial Injections: 2.5 lakh units per shift.
  • Dry Injections: 3.5 lakh units per shift.
  • Small Volume Parenterals (SVP): 4.5 lakh units per shift.

Vadgas, Viramgam: A Multifaceted Manufacturing Hub

The Vadgas, Viramgam facility in Ahmadabad is a key part of Taj Pharmaceuticals’ infrastructure. Spread across multiple specialized units, this hub delivers a diverse range of pharmaceutical products to meet global healthcare needs.

Block Unit 1: Diverse Injection Solutions

This unit focuses on:

  • Liquid Injections: Ensuring rapid therapeutic effects with high production volumes.
  • General Dry Powders: Providing stable and long-lasting formulations.
  • Lyophilized Injections: Preserving drug efficacy through advanced freeze-drying techniques.
  • Prefilled Syringes: Enhancing safety and convenience in drug delivery.

Block Unit 2: Oncology Medications

Unit 2 is exclusively dedicated to producing high-quality oncology medications, with a focus on cytotoxic drugs critical for cancer treatments.

Key Oncology Products:

  • Cytotoxic Tablets and Capsules: Specialized for oral cancer therapies.
  • Liquid Injections: Offering potent chemotherapy solutions.
  • Dry Powder and Lyophilized Injections: Designed for stability and targeted efficacy.

Unit 3: Beta Lactam Antibiotics

Unit 3 specializes in Beta Lactam antibiotics, a cornerstone in treating bacterial infections. The facility ensures precise production of:

  • Tablets
  • Capsules
  • Dry Powder Injections
  • Dry Suspensions

Unit 5: US FDA-Approved Tablets and Capsules

This facility’s US FDA approval underscores its commitment to quality. The plant specializes in manufacturing:

  • Tablets
  • Capsules

Unit 6: Nutraceuticals and Food Supplements

Addressing the rising demand for health and wellness products, Unit 6 focuses on the production of:

  • Nutraceuticals
  • Food Supplements

Large Volume Parenterals (LVP) Plant: Revolutionizing IV Solutions

Taj Pharmaceuticals’ LVP facility is designed to meet the growing demand for intravenous therapies in hospitals and outpatient facilities. The plant employs advanced aseptic filling techniques for maximum safety and efficacy.

Daily Production Capacities:

  • FFS Bottles: Produces 10 million Form-Fill-Seal bottles daily, a preferred format for IV solutions.
  • Euro Cap Bottles: Capable of manufacturing 5 million bottles per day, ensuring a robust supply.

Innovation and Commitment to Global Standards

Taj Pharmaceuticals takes pride in its relentless pursuit of innovation and adherence to global standards. All its manufacturing facilities are equipped with advanced machinery and operated by highly skilled professionals, ensuring:

  • Compliance with US FDA, EU GMP, and PIC/S regulations.
  • Use of environmentally sustainable practices.
  • Scalable production to meet global demands.

Significance in the Pharmaceutical Industry

Taj Pharmaceuticals’ manufacturing prowess has positioned it as a frontrunner in the global pharmaceutical landscape. Its facilities are not just manufacturing units but centers of excellence, driving advancements in healthcare and ensuring the availability of high-quality medications worldwide.

By maintaining a focus on cutting-edge technology, stringent quality controls, and expansive production capacities, Taj Pharmaceuticals continues to fulfill its mission of improving global health outcomes.